IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, providing promising improvements throughout several healthcare and industrial applications. With its structural similarity to In a natural way derived human serum albumin, OsrHSA presents a safer, far more reliable alternate for the